Connor, Clark & Lunn Investment Management (CC&L)’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-208,054
Closed -$4.72M 1479
2025
Q2
$4.72M Sell
208,054
-25,977
-11% -$616K 0.02% 589
2025
Q1
$7.1M Sell
234,031
-8,953
-4% -$341K 0.03% 406
2024
Q4
$9.63M Buy
+242,984
New +$11M 0.04% 325
2023
Q4
Sell
-81,081
Closed -$5.7M 1357
2023
Q3
$5.7M Buy
81,081
+44,539
+122% +$3.33M 0.03% 360
2023
Q2
$2.91M Buy
36,542
+22,567
+161% +$1.63M 0.01% 507
2023
Q1
$1.01M Buy
+13,975
New +$1.09M 0.01% 710

Other funds holding ACHC

Connor, Clark & Lunn Investment Management (CC&L)'s ACHC Position: Q3 2025 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Acadia Healthcare (ACHC) in Q3 2025, closing a stake of 208,054 shares — an estimated $4.72M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ACHC in Q1 2023 and held it in 6 quarters. The position peaked at $9.63M in Q4 2024. 270 funds tracked by Wall St. Rank hold ACHC as of Q3 2025.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Acadia Healthcare position as of Q3 2025 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 208,054 Acadia Healthcare shares in Q3 2025, an estimated $4.72M.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Acadia Healthcare in Q1 2023 and held it in 6 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Acadia Healthcare position peaked at $9.63M in Q4 2024.
  • 270 funds tracked by Wall St. Rank held Acadia Healthcare as of Q3 2025.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2025, filed 13 Nov 2025.